Business Context and Reporting Period
Company: Aimei Health Technology Co., Ltd. (AFJK), a Cayman Islands exempted company and blank check SPAC.
Reporting Date: June 19, 2024.
Event: Entry into a definitive Business Combination Agreement (Merger Agreement) with United Hydrogen Group Inc. ("United Hydrogen"). The transaction involves a series of mergers where United Hydrogen will become a wholly-owned subsidiary of a new public entity ("Pubco"), and Aimei Health will merge into Pubco.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins: The filing text does not provide specific revenue, profit, cash flow, or margin figures for Aimei Health or United Hydrogen. As a blank check company, Aimei Health's financials are primarily cash held in trust.
Liquidity and Debt:
- Net Tangible Assets Condition: The transaction requires Aimei Health to have at least $5,000,001 of net tangible assets upon closing after giving effect to shareholder redemptions.
- Debt: The filing notes that all "Sponsor Loans" and expenses incurred by Aimei Health must be paid off on or prior to Closing as a condition to consummation.
Material Changes and Transaction Structure
Share Exchange Mechanics:
- United Hydrogen Shares: Converted into Pubco Class A Ordinary Shares based on an Exchange Ratio (specific ratio not disclosed in this text).
- Aimei Health Units: Automatically detached into one Ordinary Share and one Right.
- Aimei Health Ordinary Shares: Unredeemed shares convert one-for-one into Pubco Class A Ordinary Shares.
- Aimei Health Rights: Every five Rights convert into one Pubco Class A Ordinary Share.
Related Agreements:
- Support Agreements: Executed with Requisite Shareholders of United Hydrogen and Founder Shareholders of Aimei Health to vote in favor of the merger.
- Lock-Up Agreement: Certain United Hydrogen shareholders are subject to a lock-up period of six months post-closing, or until the share price exceeds $12.00 for 20 of 30 trading days (starting 150 days post-closing).
- Registration Rights: Agreements established for both Founder and Seller shareholders to register securities for resale.
Guidance, Outlook, Risks, and Conditions
Conditions to Closing:
- Shareholder approval from both Aimei Health and United Hydrogen.
- Effectiveness of the Registration Statement (Form F-4).
- Nasdaq listing of Pubco Class A Ordinary Shares.
- Regulatory approvals, including potential approval from the China Securities Regulatory Commission.
- Payment of all Aimei Health expenses and Sponsor Loans.
Termination Rights: The agreement may be terminated if conditions are not met by March 31, 2025, if shareholder approval is not obtained, or if the Reorganization is not completed by December 31, 2024.
Risks and Forward-Looking Statements:
- Failure to obtain shareholder or regulatory approvals.
- Significant redemption requests by Aimei Health public shareholders reducing net tangible assets below the $5,000,001 threshold.
- Disruption of United Hydrogen's operations during the transaction process.
- Volatility in Aimei Health's securities price.
- Changes in laws or regulations affecting the business combination.
Investor Verification Checklist
- Exchange Ratio: Verify the specific Exchange Ratio for United Hydrogen shares to Pubco shares, as it is not detailed in this summary.
- Redemption Levels: Monitor the percentage of Aimei Health shareholders redeeming shares to ensure the $5,000,001 net tangible asset condition is met.
- Regulatory Approvals: Track the status of approvals from the China Securities Regulatory Commission and Nasdaq.
- Form F-4: Review the upcoming Registration Statement on Form F-4 for detailed pro forma financials and risk factors.
- Lock-Up Expiration: Note the specific dates and price triggers ($12.00) for the release of the Seller Lock-Up Agreement.